Ring Finger Protein 2 Promotes Oxidative Stress and Mitochondrial Dysfunction in Doxorubicin-Induced Cardiotoxicity Via the Mercaptopyruvate Sulfurtransferase/Hydrogen Sulfide Pathway.

BACKGROUND: Doxorubicin, a broad-spectrum chemotherapy drug, is often associated with dosage-dependent cardiotoxicity, which results in its limited clinical application. A therapeutic dose of doxorubicin can activate cardiac ubiquitin-proteasome system, whereas the role and potential mechanisms of this process in doxorubicin-induced cardiomyopathy (DIC) remain unclear. Herein, we assessed the potential role and therapeutic value of RNF2 (ring finger protein 2) on doxorubicin-induced cardiac damage. METHODS: Cardiomyocyte-specific RNF2 knockout or overexpression mice received doxorubicin intraperitoneal injection to establish the DIC model. The effects of RNF2 and its downstream mediators were explored through RNA sequencing, immunoprecipitation mass spectrometry analysis, and protein pulldown analysis. RESULTS: The expression of RNF2 was significantly increased in doxorubicin-treated murine myocardium and neonatal rat ventricular myocytes. Cardiomyocyte-specific RNF2 overexpression resulted in exaggerated DIC accompanied by increased cardiac dysfunction, fibrosis and apoptosis. Cardiac damage was mitigated in α-myosin heavy chain promoter-driven heterozygous-Cre(+)/RNF2-floxed mice. Previous studies have demonstrated that mitochondrial dysfunction and oxidative stress are crucial in DIC and are promoted by RNF2 overexpression and impeded by RNF2 knockout. Mechanistically, RNF2 directly interacted with mercaptopyruvate sulfurtransferase, followed by the ubiquitination and accelerated degradation of mercaptopyruvate sulfurtransferase to decrease hydrogen sulfide accumulation, thereby contributing to more severe oxidative damage and mitochondrial morphofunctional defects. Moreover, mercaptopyruvate sulfurtransferase overexpression or hydrogen sulfide supplementation in cardiomyocyte-specific RNF2-overexpressing mice restored cardiac performance after doxorubicin challenge. CONCLUSIONS: Our findings reveal the role of RNF2 in oxidative stress and mitochondrial homeostasis and the progression of DIC, suggesting that targeting RNF2 may be a potential therapeutic benefit for DIC.